These pathways are activated by both cancer cells and inflammatory stromal components, emphasizing the necessity for a comprehensive understanding of the interplay between angiogenic (VEGF, HGF) and immunoregulatory (IL-7, LIF) signals to fully comprehend the mechanisms of immune escape [113]. This evidence concerns the gene IL7 and cancer.